Evidence map›Paper›PMID 36959210›Full record

ArticleNPJ biofilms and microbiomes2023

Mucin glycans drive oral microbial community composition and function.

Chloe M Wu, Kelsey M Wheeler, Gerardo Cárcamo-Oyarce, Kazuhiro Aoki, Abigail McShane, Sujit S Datta, Jessica L Mark Welch, Michael Tiemeyer, Ann L Griffen, Katharina Ribbeck

Open access · goldFull text read
In one paragraph

Article in NPJ biofilms and microbiomes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. α2-3-Sialylated Glycoproteins AttenuateInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. [Research Progress on Drug Intervention to Inhibit Dental Plaque Biofilm Formation bySichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Chloe M WuDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Kelsey M WheelerDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Gerardo Cárcamo-OyarceDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Kazuhiro AokiComplex Carbohydrate Research Center, University of Georgia, Athens, GA, USA.ORCID 0000-0003-0029-4291
Abigail McShaneDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Sujit S DattaChemical and Biological Engineering, Princeton University, Princeton, NJ, USA.
Jessica L Mark WelchDepartment of Microbiology, The Forsyth Institute, Cambridge, MA, USA.ORCID 0000-0003-0696-2334
Michael TiemeyerComplex Carbohydrate Research Center, University of Georgia, Athens, GA, USA.
Ann L GriffenDepartment of Dentistry, Nationwide Children's Hospital, Columbus, OH, USA.
Katharina RibbeckDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. ribbeck@mit.edu.ORCID 0000-0001-8260-338X
Massachusetts Institute of Technology · USUniversity of Georgia · USNationwide Children's Hospital · USPrinceton University · US

Funding

TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LEVINE, STUART S · 1985 to 2020
$25.6M
Mucin Glycans in the Regulation of Microbial VirulenceR01EB017755 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI RIBBECK, KATHARINA · 2013 to 2022
$3.6M
NIBIB NIH HHS R01 EB017755NIEHS NIH HHS P30 ES002109NIH HHS R01-EB017755-041745302
6 · The paper itself

Abstract

Human microbiome composition is closely tied to health, but how the host manages its microbial inhabitants remains unclear. One important, but understudied, factor is the natural host environment: mucus, which contains gel-forming glycoproteins (mucins) that display hundreds of glycan structures with potential regulatory function. Leveraging a tractable culture-based system to study how mucins influence oral microbial communities, we found that mucin glycans enable the coexistence of diverse microbes, while resisting disease-associated compositional shifts. Mucins from tissues with unique glycosylation differentially tuned microbial composition, as did isolated mucin glycan libraries, uncovering the importance of specific glycan patterns in microbiome modulation. We found that mucins shape microbial communities in several ways: serving as nutrients to support metabolic diversity, organizing spatial structure through reduced aggregation, and possibly limiting antagonism between competing taxa. Overall, this work identifies mucin glycans as a natural host mechanism and potential therapeutic intervention to maintain healthy microbial communities.

Indexed as

MicrobiotaMucinsGlycosylationHumansMucusPolysaccharidesMucinsPolysaccharides

Identifiers

PMID36959210
PMCPMC10036478
OpenAlexW4360619129

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read75
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.